Global Orthobiologics Market Assessment, By Product [Demineralized Bone Matrix, Viscosupplements, Synthetic Bone Substitutes, Allografts, Bone Growth Factors, Others], By Application [Reconstructive and Fracture Surgery, Osteoarthritis and Degenerative Arthritis, Spinal Fusion, Soft Tissue Repair, Maxillofacial and Dental, Others], By End-user [Hospitals, Ambulatory and Trauma Care Centers, Orthopedic Clinics, Dental Clinics and Facilities, Others], By Region, Opportunities and Forecast, 2017-2031F

Global orthobiologics market is projected to witness a CAGR of 6.08% during the forecast period 2024-2031, growing from USD 7.01 billion in 2023 to USD 11.24 billion in 2031.

Orthobiologics Market Size, Share | In-depth Analysis 2031

Global Orthobiologics Market Assessment, Opportunities and Forecast, 2017-2031F

The increasing demand for demineralized bone matrix (DBM) in a variety of orthopedic surgeries, such as spinal fusion, bone fractures, and joint reconstructions, is primarily driving the orthobiologics market growth. Moreover, advancements in technology, an aging population, growth in orthopedic conditions, and higher demand for less invasive surgical procedures are positively impacting the market growth.

FAQs

Industry Reports

Blogs

Case Studies

Industry News

Press Release

Infographics